A new pooled analysis of the FIBRONEER™-IPF and FIBRONEER™-ILD trials resulted in a nominally significant reduction in the risk of death by 59% in patients who received 18mg nerandomilast without ...

Conflicting findings in environmental epidemiology have long stalled consensus on the health effects of toxic chemicals. A new study suggests that one major reason for these inconsistencies may be the ...

The five medical centers overseen by the University of California have collected more than a decade's worth of surgical data, allowing it to streamline care and improve financial margins, which has ...

Arcus Biosciences, Inc. (NYSE:RCUS), a clinical-stage, global biopharmaceutical company focused on developing differentiated molecules for patients with cancer and inflammatory and autoimmune diseases ...

This systematic literature review and pooled rates analysis investigated the standard of care for patients with heart failure in the US post hospital discharge. Results: There were 31 studies that met ...

Deep, stable and durable reductions in kallikrein observed Among 32 patients who received a 50 mg dose of lonvo-z as of data cutoff: 31 (97%) were attack-free and long-term prophylaxis (LTP)-free 24 ...

Delandistrogene moxeparvovec demonstrates a consistent safety profile, with most adverse events occurring within 90 days post-infusion. Gastrointestinal events are the most common treatment-related ...

April 28, 2025-- Conflicting findings in environmental epidemiology have long stalled consensus on the health effects of toxic chemicals. A new study by Columbia University Mailman School of Public ...